pelacarsen

The latest news about pelacarsen: headlines, AI summaries and the full story from every source.

• Morgan Stanley Highlights Amgen's Competitive Position After Novartis Heart Drug Trial Failure TheStreet · September 22, 2026, 00:07 UTC
• Novartis' Pelacarsen Clinical Failure Impacts Cardiovascular Drug Race and Eli Lilly Motley Fool · September 14, 2026, 08:44 UTC
• Royalty Pharma's Pelacarsen Fails Phase 3 Trial; Focus Shifts to Spinraza Royalties Yahoo Finance · September 10, 2026, 18:20 UTC